{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T07:31:57Z","timestamp":1792740717740,"version":"4.5.0"},"reference-count":84,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revue Neurologique"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.neurol.2020.06.016","type":"journal-article","created":{"date-parts":[[2020,10,10]],"date-time":"2020-10-10T01:41:56Z","timestamp":1602294116000},"page":"39-50","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["MRI characteristics of MOG-Ab associated disease in adults: An update"],"prefix":"10.1016","volume":"177","author":[{"given":"N.","family":"Shor","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Deschamps","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Cobo Calvo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Maillart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Zephir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Ciron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Papeix","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Durand-Dubief","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Ruet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"X.","family":"Ayrignac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Deiva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Laplaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Bourre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Audoin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Collongues","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Vukusic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Cotton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Marignier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neurol.2020.06.016_bib0425","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1001\/jamaneurol.2018.1814","article-title":"Association of MOG-IgG Serostatus With Relapse After Acute Disseminated Encephalomyelitis and Proposed Diagnostic Criteria for MOG-IgG-Associated Disorders","volume":"75","author":"L\u00f3pez-Chiriboga","year":"2018","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.neurol.2020.06.016_bib0430","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000008479","article-title":"Relevance of antibodies to myelin oligodendrocyte glycoprotein in CSF of seronegative cases","author":"Mariotto","year":"2019","journal-title":"Neurology"},{"key":"10.1016\/j.neurol.2020.06.016_bib0435","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/s41582-018-0112-x","article-title":"Myelin oligodendrocyte glycoprotein antibodies in neurological disease","volume":"15","author":"Reindl","year":"2019","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.neurol.2020.06.016_bib0440","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1001\/jamaneurol.2019.3656","article-title":"Coexistence of Myelin Oligodendrocyte Glycoprotein and Aquaporin-4 Antibodies in Adult and Pediatric Patients","volume":"77","author":"Kunchok","year":"2020","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.neurol.2020.06.016_bib0445","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1111\/ene.13315","article-title":"Etiologies of acute demyelinating optic neuritis: an observational study of 110 patients","volume":"24","author":"Deschamps","year":"2017","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.neurol.2020.06.016_bib0450","article-title":"MOG-Ab prevalence in optic neuritis and clinical predictive factors for diagnosis","author":"Ducloyer","year":"2019","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.neurol.2020.06.016_bib0455","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1111\/ene.13791","article-title":"Myelin oligodendrocyte glycoprotein antibody-associated demyelination: comparison between onset phenotypes","volume":"26","author":"Zhou","year":"2019","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.neurol.2020.06.016_bib0460","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1177\/1352458515593406","article-title":"Radiological differentiation of optic neuritis with myelin oligodendrocyte glycoprotein antibodies, aquaporin-4 antibodies, and multiple sclerosis","volume":"22","author":"Ramanathan","year":"2016","journal-title":"Mult Scler"},{"key":"10.1016\/j.neurol.2020.06.016_bib0465","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1111\/ene.14089","article-title":"Clinical, imaging and follow-up study of optic neuritis associated with myelin oligodendrocyte glycoprotein antibody: a multicentre study of 62 adult patients","volume":"27","author":"Shor","year":"2020","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.neurol.2020.06.016_bib0470","doi-asserted-by":"crossref","first-page":"e1858","DOI":"10.1212\/WNL.0000000000005560","article-title":"Clinical spectrum and prognostic value of CNS MOG autoimmunity in adults: The MOGADOR study","volume":"90","author":"Cobo-Calvo","year":"2018","journal-title":"Neurology"},{"key":"10.1016\/j.neurol.2020.06.016_bib0475","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.msard.2019.02.023","article-title":"Clinical characteristics of myelin oligodendrocyte glycoprotein antibody neuromyelitis optica spectrum disorder","volume":"30","author":"Salama","year":"2019","journal-title":"Mult Scler Relat Disord"},{"key":"10.1016\/j.neurol.2020.06.016_bib0480","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.jns.2018.11.029","article-title":"The prevalence and prognostic value of myelin oligodendrocyte glycoprotein antibody in adult optic neuritis","volume":"396","author":"Liu","year":"2019","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.neurol.2020.06.016_bib0485","first-page":"1381","article-title":"Seroprevalence and clinical phenotype of MOG-IgG-associated disorders in Sri Lanka","volume":"90","author":"Senanayake","year":"2019","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.neurol.2020.06.016_bib0490","doi-asserted-by":"crossref","first-page":"4015075","DOI":"10.1155\/2019\/4015075","article-title":"Different Characteristics of Aquaporin-4 and Myelin Oligodendrocyte Glycoprotein Antibody-Seropositive Male Optic Neuritis in China","volume":"2019","author":"Song","year":"2019","journal-title":"J Ophthalmol"},{"key":"10.1016\/j.neurol.2020.06.016_bib0495","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1007\/s00415-017-8615-8","article-title":"Optic neuritis in patients with anti-MOG antibodies spectrum disorder: MRI and clinical features from a large multicentric cohort in France","volume":"264","author":"Biotti","year":"2017","journal-title":"J Neurol"},{"key":"10.1016\/j.neurol.2020.06.016_bib0500","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1136\/bjophthalmol-2017-311177","article-title":"Clinical features of demyelinating optic neuritis with seropositive myelin oligodendrocyte glycoprotein antibody in Chinese patients","volume":"102","author":"Zhao","year":"2018","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.neurol.2020.06.016_bib0505","doi-asserted-by":"crossref","first-page":"101965","DOI":"10.1016\/j.msard.2020.101965","article-title":"Prodromal headache in MOG-antibody positive optic neuritis","volume":"40","author":"Asseyer","year":"2020","journal-title":"Mult Scler Relat Disord"},{"key":"10.1016\/j.neurol.2020.06.016_bib0510","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.ajo.2018.07.020","article-title":"Myelin Oligodendrocyte Glycoprotein Antibody-Positive Optic Neuritis: Clinical Characteristics, Radiologic Clues, and Outcome","volume":"195","author":"Chen","year":"2018","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.neurol.2020.06.016_bib0515","doi-asserted-by":"crossref","first-page":"3128","DOI":"10.1093\/brain\/awx276","article-title":"Clinical presentation and prognosis in MOG-antibody disease: a UK study","volume":"140","author":"Jurynczyk","year":"2017","journal-title":"Brain"},{"key":"10.1016\/j.neurol.2020.06.016_bib0520","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1186\/s12974-016-0718-0","article-title":"MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 2: Epidemiology, clinical presentation, radiological and laboratory features, treatment responses, and long-term outcome","volume":"13","author":"Jarius","year":"2016","journal-title":"J Neuroinflammation"},{"key":"10.1016\/j.neurol.2020.06.016_bib0525","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1007\/s00415-016-8147-7","article-title":"Clinical spectrum associated with MOG autoimmunity in adults: significance of sharing rodent MOG epitopes","volume":"263","author":"Sep\u00falveda","year":"2016","journal-title":"J Neurol"},{"key":"10.1016\/j.neurol.2020.06.016_bib0530","doi-asserted-by":"crossref","first-page":"e163","DOI":"10.1212\/NXI.0000000000000163","article-title":"Antibodies to MOG in adults with inflammatory demyelinating disease of the CNS","volume":"2","author":"Kim","year":"2015","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"10.1016\/j.neurol.2020.06.016_bib0535","doi-asserted-by":"crossref","first-page":"e131","DOI":"10.1212\/NXI.0000000000000131","article-title":"Anti-MOG antibodies are frequently associated with steroid-sensitive recurrent optic neuritis","volume":"2","author":"Chalmoukou","year":"2015","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"10.1016\/j.neurol.2020.06.016_bib0540","first-page":"15","article-title":"Chronic relapsing inflammatory optic neuropathy (CRION): a manifestation of myelin oligodendrocyte glycoprotein antibodies","author":"Lee","year":"2018","journal-title":"J Neuroinflammation"},{"key":"10.1016\/j.neurol.2020.06.016_bib0545","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s00415-013-6957-4","article-title":"Chronic relapsing inflammatory optic neuropathy: a systematic review of 122 cases reported","volume":"261","author":"Petzold","year":"2014","journal-title":"J Neurol"},{"key":"10.1016\/j.neurol.2020.06.016_bib0550","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1001\/archopht.119.9.1299","article-title":"Optic Perineuritis: Clinical and Radiographic Features","volume":"119","author":"Purvin","year":"2001","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.neurol.2020.06.016_bib0555","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s10072-017-2897-6","article-title":"Migraine with aura and white matter lesions: an MRI study","volume":"38","author":"Uggetti","year":"2017","journal-title":"Neurological Sciences"},{"key":"10.1016\/j.neurol.2020.06.016_bib0560","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1111\/ene.13753","article-title":"Acute idiopathic optic neuritis: not always benign","volume":"25","author":"Deschamps","year":"2018","journal-title":"European Journal of Neurology"},{"key":"10.1016\/j.neurol.2020.06.016_bib0565","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.jneuroim.2016.02.004","article-title":"Lesion length of optic neuritis impacts visual prognosis in neuromyelitis optica","volume":"293","author":"Akaishi","year":"2016","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.neurol.2020.06.016_bib0570","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1136\/jnnp-2014-310206","article-title":"MRI and retinal abnormalities in isolated optic neuritis with myelin oligodendrocyte glycoprotein and aquaporin-4 antibodies: a comparative study","volume":"87","author":"Akaishi","year":"2016","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.neurol.2020.06.016_bib0575","first-page":"405","article-title":"Different magnetic resonance imaging features between MOG antibody- and AQP4 antibody-mediated disease: A Chinese cohort study","author":"Chen","year":"2019","journal-title":"Journal of the Neurological Sciences"},{"key":"10.1016\/j.neurol.2020.06.016_bib0580","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/j.ophtha.2019.04.042","article-title":"Epidemiologic and Clinical Characteristics of Optic Neuritis in Japan","volume":"126","author":"Ishikawa","year":"2019","journal-title":"Ophthalmology"},{"key":"10.1016\/j.neurol.2020.06.016_bib0585","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1001\/jamaneurol.2018.3207","article-title":"Myelin Oligodendrocyte Glycoprotein Antibody\u2013Associated Demyelination Comorbid With Leber Hereditary Optic Neuropathy","volume":"76","author":"Bittner","year":"2019","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.neurol.2020.06.016_bib0590","article-title":"Clinical, Radiologic, and Prognostic Features of Myelitis Associated With Myelin Oligodendrocyte Glycoprotein Autoantibody","author":"Dubey","year":"2018","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.neurol.2020.06.016_bib0595","article-title":"Frequency and characteristics of short versus longitudinally extensive myelitis in adults with MOG antibodies: A retrospective multicentric study","author":"Ciron","year":"2019","journal-title":"Mult Scler"},{"key":"10.1016\/j.neurol.2020.06.016_bib0600","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1136\/jnnp-2014-308346","article-title":"Clinical and neuroradiological differences of paediatric acute disseminating encephalomyelitis with and without antibodies to the myelin oligodendrocyte glycoprotein","volume":"86","author":"Baumann","year":"2015","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.neurol.2020.06.016_bib0605","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.neurad.2019.06.001","article-title":"MRI features of demyelinating disease associated with anti-MOG antibodies in adults","volume":"46","author":"Den\u00e8ve","year":"2019","journal-title":"J Neuroradiol"},{"key":"10.1016\/j.neurol.2020.06.016_bib0610","doi-asserted-by":"crossref","first-page":"e1912732","DOI":"10.1001\/jamanetworkopen.2019.12732","article-title":"Comparison of Clinical Outcomes of Transverse Myelitis Among Adults With Myelin Oligodendrocyte Glycoprotein Antibody vs Aquaporin-4 Antibody Disease","volume":"2","author":"Mariano","year":"2019","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.neurol.2020.06.016_bib0615","article-title":"MOG-related disorders: A new cause of imaging-negative myelitis?","author":"Macaron","year":"2019","journal-title":"Mult Scler"},{"key":"10.1016\/j.neurol.2020.06.016_bib0620","article-title":"Frequency and characteristics of MRI-negative myelitis associated with MOG autoantibodies","author":"Sechi","year":"2020","journal-title":"Mult Scler"},{"key":"10.1016\/j.neurol.2020.06.016_bib0625","first-page":"5","article-title":"Reversible paraspinal muscle hyperintensity in anti-MOG antibody\u2013associated transverse myelitis","author":"Pandit","year":"2017","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"10.1016\/j.neurol.2020.06.016_bib0630","article-title":"Spinal cord lesions and atrophy in NMOSD with AQP4-IgG and MOG-IgG associated autoimmunity","author":"Chien","year":"2018","journal-title":"Mult Scler"},{"key":"10.1016\/j.neurol.2020.06.016_bib0635","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1177\/1352458515591071","article-title":"Antibodies to myelin oligodendrocyte glycoprotein in aquaporin 4 antibody seronegative longitudinally extensive transverse myelitis: Clinical and prognostic implications","volume":"22","author":"Cobo-Calvo","year":"2016","journal-title":"Mult Scler"},{"key":"10.1016\/j.neurol.2020.06.016_bib0640","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1001\/jamaneurol.2013.5857","article-title":"Neuromyelitis optica spectrum disorders with aquaporin-4 and myelin-oligodendrocyte glycoprotein antibodies: a comparative study","volume":"71","author":"Kitley","year":"2014","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.neurol.2020.06.016_bib0645","doi-asserted-by":"crossref","DOI":"10.1007\/s00415-020-09755-x","article-title":"MOG encephalomyelitis: distinct clinical MRI and CSF features in patients with longitudinal extensive transverse myelitis as first clinical presentation","author":"Loos","year":"2020","journal-title":"J Neurol"},{"key":"10.1016\/j.neurol.2020.06.016_bib0650","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.msard.2019.01.021","article-title":"Radiological characteristics of myelin oligodendrocyte glycoprotein antibody disease","volume":"29","author":"Salama","year":"2019","journal-title":"Mult Scler Relat Disord"},{"key":"10.1016\/j.neurol.2020.06.016_bib0655","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1742-2094-9-14","article-title":"Contrasting disease patterns in seropositive and seronegative neuromyelitis optica: A multicentre study of 175 patients","volume":"9","author":"Jarius","year":"2012","journal-title":"J Neuroinflammation"},{"key":"10.1016\/j.neurol.2020.06.016_bib0660","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1093\/brain\/aww350","article-title":"Distinct brain imaging characteristics of autoantibody-mediated CNS conditions and multiple sclerosis","volume":"140","author":"Jurynczyk","year":"2017","journal-title":"Brain"},{"key":"10.1016\/j.neurol.2020.06.016_bib0665","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1001\/jamaneurol.2017.3196","article-title":"Seizures and Encephalitis in Myelin Oligodendrocyte Glycoprotein IgG Disease vs Aquaporin 4 IgG Disease","volume":"75","author":"Hamid","year":"2018","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.neurol.2020.06.016_bib0670","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.msard.2019.03.018","article-title":"A case of ADEM-like presentation with anti-MOG antibody following tumefactive demyelinating lesion","volume":"31","author":"Miyaue","year":"2019","journal-title":"Mult Scler Relat Disord"},{"key":"10.1016\/j.neurol.2020.06.016_bib0675","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1097\/WCO.0000000000000683","article-title":"Pseudotumoral demyelinating lesions: diagnostic approach and long-term outcome","volume":"32","author":"Hardy","year":"2019","journal-title":"Curr Opin Neurol"},{"key":"10.1016\/j.neurol.2020.06.016_bib0680","doi-asserted-by":"crossref","first-page":"e175","DOI":"10.1212\/NXI.0000000000000175","article-title":"Fulminant demyelinating encephalomyelitis: Insights from antibody studies and neuropathology","volume":"2","author":"Di Pauli","year":"2015","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"10.1016\/j.neurol.2020.06.016_bib0685","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1002\/acn3.712","article-title":"Brain histopathological study and prognosis in MOG antibody-associated demyelinating pseudotumor","volume":"6","author":"Shu","year":"2019","journal-title":"Ann Clin Transl Neurol"},{"key":"10.1016\/j.neurol.2020.06.016_bib0690","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.msard.2018.10.012","article-title":"Aphasic status epilepticus preceding tumefactive left hemisphere lesion in anti-MOG antibody associated disease","volume":"27","author":"Katsuse","year":"2019","journal-title":"Mult Scler Relat Disord"},{"key":"10.1016\/j.neurol.2020.06.016_bib0695","doi-asserted-by":"crossref","first-page":"2420","DOI":"10.1007\/s00415-017-8635-4","article-title":"Clinical spectrum and IgG subclass analysis of anti-myelin oligodendrocyte glycoprotein antibody-associated syndromes: a multicenter study","volume":"264","author":"Mariotto","year":"2017","journal-title":"J Neurol"},{"key":"10.1016\/j.neurol.2020.06.016_bib0700","article-title":"Persistent MOG-IgG positivity is a predictor of recurrence in MOG-IgG-associated optic neuritis, encephalitis and myelitis","author":"Oliveira","year":"2018","journal-title":"Mult Scler"},{"key":"10.1016\/j.neurol.2020.06.016_bib0705","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1016\/j.ophtha.2018.03.041","article-title":"Aquaporin-4 and Myelin Oligodendrocyte Glycoprotein Autoantibody Status Predict Outcome of Recurrent Optic Neuritis","volume":"125","author":"Jitprapaikulsan","year":"2018","journal-title":"Ophthalmology"},{"key":"10.1016\/j.neurol.2020.06.016_bib0710","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1136\/jnnp-2018-319235","article-title":"Perivascular enhancement in anti-MOG antibody demyelinating disease of the CNS","volume":"90","author":"Komatsu","year":"2019","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.neurol.2020.06.016_bib0715","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1186\/s12974-016-0719-z","article-title":"MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 3: Brainstem involvement - frequency, presentation and outcome","volume":"13","author":"Jarius","year":"2016","journal-title":"J Neuroinflammation"},{"key":"10.1016\/j.neurol.2020.06.016_bib0720","first-page":"13","article-title":"MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 3: Brainstem involvement - frequency, presentation and outcome","author":"Jarius","year":"2016","journal-title":"J Neuroinflammation"},{"key":"10.1016\/j.neurol.2020.06.016_bib0725","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.msard.2018.02.006","article-title":"MOG-antibody demyelinating diseases: a case of post-partum severe rhombencephalitis and transverse myelitis","volume":"21","author":"Vecchio","year":"2018","journal-title":"Mult Scler Relat Disord"},{"key":"10.1016\/j.neurol.2020.06.016_bib0730","doi-asserted-by":"crossref","first-page":"e543","DOI":"10.1212\/NXI.0000000000000543","article-title":"Cranial nerve involvement in patients with MOG antibody-associated disease","volume":"6","author":"Cobo-Calvo","year":"2019","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"10.1016\/j.neurol.2020.06.016_bib0735","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1007\/s10072-018-3668-8","article-title":"Bilateral trigeminal root entry zone enhancement in MOG-IgG-associated brainstem encephalitis","volume":"40","author":"Shen","year":"2019","journal-title":"Neurol Sci"},{"key":"10.1016\/j.neurol.2020.06.016_bib0740","article-title":"Quantitative brain lesion distribution may distinguish MOG-ab and AQP4-ab neuromyelitis optica spectrum disorders","author":"Yang","year":"2019","journal-title":"Eur Radiol"},{"key":"10.1016\/j.neurol.2020.06.016_bib0745","first-page":"94","article-title":"Does area postrema syndrome occur in myelin oligodendrocyte glycoprotein-IgG-associated disorders (MOGAD)?","author":"Kunchok","year":"2019","journal-title":"Neurology"},{"key":"10.1016\/j.neurol.2020.06.016_bib0750","doi-asserted-by":"crossref","first-page":"e16","DOI":"10.1111\/ene.13483","article-title":"CLIPPERS mimickers: relapsing brainstem encephalitis associated with anti-MOG antibodies","volume":"25","author":"Berzero","year":"2018","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.neurol.2020.06.016_bib0755","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1111\/ene.13790","article-title":"Encephalitis is an important clinical component of myelin oligodendrocyte glycoprotein antibody associated demyelination: a single-center cohort study in Shanghai, China","volume":"26","author":"Wang","year":"2019","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.neurol.2020.06.016_bib0760","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1002\/ana.25131","article-title":"Autoimmune encephalitis epidemiology and a comparison to infectious encephalitis","volume":"83","author":"Dubey","year":"2018","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neurol.2020.06.016_bib0765","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1136\/jnnp-2016-315094","article-title":"Bilateral frontal cortex encephalitis and paraparesis in a patient with anti-MOG antibodies","volume":"88","author":"Fujimori","year":"2017","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.neurol.2020.06.016_bib0770","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.msard.2019.06.010","article-title":"Optic neuritis, encephalitis and leptomeningeal enhancement in a patient with anti-MOG antibodies: A case study","volume":"34","author":"Haddad","year":"2019","journal-title":"Multiple Sclerosis and Related Disorders"},{"key":"10.1016\/j.neurol.2020.06.016_bib0775","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1002\/ana.24117","article-title":"Overlapping demyelinating syndromes and anti\u2013N-methyl-D-aspartate receptor encephalitis","volume":"75","author":"Titulaer","year":"2014","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neurol.2020.06.016_bib0780","doi-asserted-by":"crossref","first-page":"e141","DOI":"10.1212\/NXI.0000000000000141","article-title":"NMDA receptor antibodies: A rare association in inflammatory demyelinating diseases","volume":"2","author":"Ramberger","year":"2015","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"10.1016\/j.neurol.2020.06.016_bib0785","first-page":"10","article-title":"Co-occurrence of Anti-N-Methyl-D-Aspartate Receptor Encephalitis and Anti-myelin Oligodendrocyte Glycoprotein Inflammatory Demyelinating Diseases: A Clinical Phenomenon to Be Taken Seriously","author":"Ren","year":"2019","journal-title":"Front Neurol"},{"key":"10.1016\/j.neurol.2020.06.016_bib0790","first-page":"4","article-title":"MOG antibody\u2013positive, benign, unilateral, cerebral cortical encephalitis with epilepsy","author":"Ogawa","year":"2017","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"10.1016\/j.neurol.2020.06.016_bib0795","doi-asserted-by":"crossref","first-page":"2481","DOI":"10.1007\/s00415-019-09440-8","article-title":"Unilateral cortical FLAIR-hyperintense Lesions in Anti-MOG-associated Encephalitis with Seizures (FLAMES): characterization of a distinct clinico-radiographic syndrome","volume":"266","author":"Budhram","year":"2019","journal-title":"J Neurol"},{"key":"10.1016\/j.neurol.2020.06.016_bib0800","doi-asserted-by":"crossref","first-page":"577002","DOI":"10.1016\/j.jneuroim.2019.577002","article-title":"Two Japanese cases of anti-MOG antibody-associated encephalitis that mimicked neuro-Beh\u00e7et's disease","volume":"334","author":"Fujimori","year":"2019","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.neurol.2020.06.016_bib0805","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1212\/WNL.0000000000003713","article-title":"Investigations in GABAA receptor antibody-associated encephalitis","volume":"88","author":"Spatola","year":"2017","journal-title":"Neurology"},{"key":"10.1016\/j.neurol.2020.06.016_bib0810","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1001\/jamaneurol.2019.2940","article-title":"Serial Anti\u2013Myelin Oligodendrocyte Glycoprotein Antibody Analyses and Outcomes in Children With Demyelinating Syndromes","volume":"77","author":"Waters","year":"2020","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.neurol.2020.06.016_bib0815","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1002\/jmri.25528","article-title":"Diffusion-weighted imaging helps differentiate multiple sclerosis and neuromyelitis optica-related acute optic neuritis","volume":"45","author":"Wan","year":"2017","journal-title":"J Magn Reson Imaging"},{"key":"10.1016\/j.neurol.2020.06.016_bib0820","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1097\/RCT.0000000000000724","article-title":"Differentiating Neuromyelitis Optica-Related and Multiple Sclerosis-Related Acute Optic Neuritis Using Conventional Magnetic Resonance Imaging Combined With Readout-Segmented Echo-Planar Diffusion-Weighted Imaging","volume":"42","author":"Lu","year":"2018","journal-title":"J Comput Assist Tomogr"},{"key":"10.1016\/j.neurol.2020.06.016_bib0825","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1097\/RCT.0000000000000974","article-title":"Role of Diffusional Kurtosis Imaging in Differentiating Neuromyelitis Optica-Related and Multiple Sclerosis-Related Acute Optic Neuritis: Comparison With Diffusion-Weighted Imaging","volume":"44","author":"Lu","year":"2020","journal-title":"J Comput Assist Tomogr"},{"key":"10.1016\/j.neurol.2020.06.016_bib0830","article-title":"3D PSIR MRI at 3\u00a0Tesla improves detection of spinal cord lesions in multiple sclerosis","author":"Mirafzal","year":"2019","journal-title":"J Neurol"},{"key":"10.1016\/j.neurol.2020.06.016_bib0835","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.3174\/ajnr.A3637","article-title":"Optimized T1-MPRAGE sequence for better visualization of spinal cord multiple sclerosis lesions at 3T","volume":"34","author":"Nair","year":"2013","journal-title":"AJNR Am J Neuroradiol"},{"key":"10.1016\/j.neurol.2020.06.016_bib0840","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1002\/ana.23909","article-title":"Low myo-inositol indicating astrocytic damage in a case series of neuromyelitis optica","volume":"74","author":"Ciccarelli","year":"2013","journal-title":"Ann Neurol"}],"container-title":["Revue Neurologique"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0035378720306792?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0035378720306792?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T05:42:15Z","timestamp":1758519735000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0035378720306792"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":84,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["S0035378720306792"],"URL":"https:\/\/doi.org\/10.1016\/j.neurol.2020.06.016","relation":{},"ISSN":["0035-3787"],"issn-type":[{"value":"0035-3787","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"MRI characteristics of MOG-Ab associated disease in adults: An update","name":"articletitle","label":"Article Title"},{"value":"Revue Neurologique","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neurol.2020.06.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}